p53 talks to PARP: the increasing complexity of p53-induced cell death

Por Wiman, K G
Publicado em 2013

TP53: an oncogene in disguise

Por Soussi, T, Wiman, K G
Publicado no Cell Death Differ (2015)

The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?

Por Vilborg, A, Bersani, C, Wilhelm, M T, Wiman, K G
Publicado em 2011

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

Por Szekely, L, Selivanova, G, Magnusson, K P, Klein, G, Wiman, K G
Publicado em 1993

Activation of a translocated c-myc gene: role of structural alterations in the upstream region.

Por Wiman, K G, Clarkson, B, Hayday, A C, Saito, H, Tonegawa, S, Hayward, W S
Publicado em 1984

Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth

Por Vilborg, A, Bersani, C, Wickström, M, Segerström, L, Kogner, P, Wiman, K G
Publicado em 2012

Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ

Por Bersani, C, Xu, L-D, Vilborg, A, Lui, W-O, Wiman, K G
Publicado em 2014

The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.

Por Selivanova, G, Iotsova, V, Kiseleva, E, Ström, M, Bakalkin, G, Grafström, R C, Wiman, K G
Publicado em 1996

p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

Por Bakalkin, G, Yakovleva, T, Selivanova, G, Magnusson, K P, Szekely, L, Kiseleva, E, Klein, G, Terenius, L, Wiman, K G
Publicado em 1994

p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.

Por Bakalkin, G, Selivanova, G, Yakovleva, T, Kiseleva, E, Kashuba, E, Magnusson, K P, Szekely, L, Klein, G, Terenius, L, Wiman, K G
Publicado em 1995

APR-246/PRIMA-1(MET) inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

Por Peng, X, Zhang, M-Q-Z, Conserva, F, Hosny, G, Selivanova, G, Bykov, V J N, Arnér, E S J, Wiman, K G
Publicado em 2013

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

Por Mohell, N, Alfredsson, J, Fransson, Å, Uustalu, M, Byström, S, Gullbo, J, Hallberg, A, Bykov, V J N, Björklund, U, Wiman, K G
Publicado no Cell Death Dis (2015)